Hald, J.D.
Folkestad, L.
Swan, C.Z.
Wanscher, J.
Schmidt, M.
Gjørup, H.
Haubek, D.
Leonhard, C.-H.
Larsen, D.A.
Hjortdal, J.Ø.
Harsløf, T.
Duno, M.
Lund, A.M.
Jensen, J.-E.B.
Brixen, K.
Langdahl, B.
Article History
Received: 22 January 2018
Accepted: 12 August 2018
First Online: 24 August 2018
Compliance with ethical standards
: All patients provided written informed consent. The studies were approved by the Central Danish Regional Committee on Health Research Ethics (ref-number M-20100108).
: Jannie Dahl Hald: none.Lars Folkestad: received speaker fee from Genzymes.Christer Zøylner Swan: none.Jens Wanscher: none.Malene Schmidt: none.Hans Gjørup: none.Dorte Haubek: none.Christian-Heinrich Leonhard: none.Dorte Ancher Larsen: none.Jesper Østergaard Hjortdal: none.Torben Harsløf: received speaker fee from Amgen, Eli Lilly, and Astra-Zeneca.Morten Duno: none.Allan M. Lund: none.Jens-Erik Beck Jensen: advisory board membership and speaking fees from Amgen, Eli Lilly, and MSD.Kim Brixen: none.Bente Langdahl: advisory board membership and speaking fees from Amgen, Eli Lilly, Merck, TEVA, and UCB; received research support from Novo Nordisk, Amgen, and Orkla Health.